Cargando…
Correction in article by Cosín-Sales et al. «Telemedicine for patients with valvular heart disease or aortic disease in the era of COVID-19. Response». Rev Esp Cardiol. 2021;74:362-363
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
Sociedad Española de Cardiología. Published by Elsevier España, S.L.U.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8166494/ https://www.ncbi.nlm.nih.gov/pubmed/34083167 http://dx.doi.org/10.1016/j.rec.2021.04.014 |
_version_ | 1783701515086594048 |
---|---|
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-8166494 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Sociedad Española de Cardiología. Published by Elsevier España, S.L.U. |
record_format | MEDLINE/PubMed |
spelling | pubmed-81664942021-06-01 Correction in article by Cosín-Sales et al. «Telemedicine for patients with valvular heart disease or aortic disease in the era of COVID-19. Response». Rev Esp Cardiol. 2021;74:362-363 Rev Esp Cardiol (Engl Ed) Corrections Sociedad Española de Cardiología. Published by Elsevier España, S.L.U. 2021-08 2021-06-01 /pmc/articles/PMC8166494/ /pubmed/34083167 http://dx.doi.org/10.1016/j.rec.2021.04.014 Text en © 2020 Sociedad Española de Cardiología. Published by Elsevier España, S.L.U. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Corrections Correction in article by Cosín-Sales et al. «Telemedicine for patients with valvular heart disease or aortic disease in the era of COVID-19. Response». Rev Esp Cardiol. 2021;74:362-363 |
title | Correction in article by Cosín-Sales et al. «Telemedicine for patients with valvular heart disease or aortic disease in the era of COVID-19. Response». Rev Esp Cardiol. 2021;74:362-363 |
title_full | Correction in article by Cosín-Sales et al. «Telemedicine for patients with valvular heart disease or aortic disease in the era of COVID-19. Response». Rev Esp Cardiol. 2021;74:362-363 |
title_fullStr | Correction in article by Cosín-Sales et al. «Telemedicine for patients with valvular heart disease or aortic disease in the era of COVID-19. Response». Rev Esp Cardiol. 2021;74:362-363 |
title_full_unstemmed | Correction in article by Cosín-Sales et al. «Telemedicine for patients with valvular heart disease or aortic disease in the era of COVID-19. Response». Rev Esp Cardiol. 2021;74:362-363 |
title_short | Correction in article by Cosín-Sales et al. «Telemedicine for patients with valvular heart disease or aortic disease in the era of COVID-19. Response». Rev Esp Cardiol. 2021;74:362-363 |
title_sort | correction in article by cosín-sales et al. «telemedicine for patients with valvular heart disease or aortic disease in the era of covid-19. response». rev esp cardiol. 2021;74:362-363 |
topic | Corrections |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8166494/ https://www.ncbi.nlm.nih.gov/pubmed/34083167 http://dx.doi.org/10.1016/j.rec.2021.04.014 |